Arlington Partners’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-36
Closed -$10.5K 307
2023
Q3
$10.5K Sell
36
-454
-93% -$142K ﹤0.01% 232
2023
Q2
$168K Buy
490
+202
+70% +$61.1K 0.03% 173
2023
Q1
$73.6K Buy
288
+36
+14% +$8.87K 0.01% 245
2022
Q4
$66.9K Hold
252
0.01% 192
2022
Q3
$47K Sell
252
-21
-8% -$4.51K 0.02% 200
2022
Q2
$55K Hold
273
0.02% 235
2022
Q1
$82K Sell
273
-27
-9% -$7.89K 0.02% 206
2021
Q4
$108K Buy
300
+48
+19% +$16.5K 0.03% 191
2021
Q3
$84K Hold
252
0.02% 190
2021
Q2
$77K Hold
252
0.03% 159
2021
Q1
$62K Hold
252
0.02% 213
2020
Q4
$69K Buy
+252
New +$62.6K 0.03% 92

Other funds holding ISRG

Arlington Partners's ISRG Position: Q4 2023 in Review

Arlington Partners sold out of Intuitive Surgical (ISRG) in Q4 2023, closing a stake of 36 shares — an estimated $10.5K sold.

Arlington Partners first reported a position in ISRG in Q4 2020 and held it in 12 quarters. The position peaked at $168K in Q2 2023. 1,673 funds tracked by Wall St. Rank hold ISRG as of Q4 2023.

  • Arlington Partners reported no remaining Intuitive Surgical position as of Q4 2023 after selling out during the quarter.
  • Arlington Partners sold 36 Intuitive Surgical shares in Q4 2023, an estimated $10.5K.
  • Arlington Partners first reported a position in Intuitive Surgical in Q4 2020 and held it in 12 quarters.
  • Arlington Partners's Intuitive Surgical position peaked at $168K in Q2 2023.
  • 1,673 funds tracked by Wall St. Rank held Intuitive Surgical as of Q4 2023.

Based on Arlington Partners's 13F filing for Q4 2023, filed 24 Jan 2024.